688075 Stock Overview
Engages in the research and development, production, and sale of diagnostic reagents, POCT, and biological materials.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Assure Tech (Hangzhou) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥33.89 |
| 52 Week High | CN¥45.00 |
| 52 Week Low | CN¥28.76 |
| Beta | 0.93 |
| 11 Month Change | -2.00% |
| 3 Month Change | -1.45% |
| 1 Year Change | -21.77% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -42.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688075 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 0.6% | -2.1% | 0.6% |
| 1Y | -21.8% | -20.1% | -18.5% |
Return vs Industry: 688075 underperformed the CN Medical Equipment industry which returned -19.3% over the past year.
Return vs Market: 688075 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
| 688075 volatility | |
|---|---|
| 688075 Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 688075 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688075's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 791 | Shisheng Ling | www.diareagent.com |
Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of diagnostic reagents, POCT, and biological materials. Its products are used in drug of abuse tests, infectious disease tests, fertility tests, tumor markers tests, cardiac markers tests, biochemical tests, allergy tests, and chronic disease series. Assure Tech (Hangzhou) Co., Ltd.
Assure Tech (Hangzhou) Co., Ltd. Fundamentals Summary
| 688075 fundamental statistics | |
|---|---|
| Market cap | CN¥4.31b |
| Earnings (TTM) | CN¥160.91m |
| Revenue (TTM) | CN¥511.29m |
26.8x
P/E Ratio8.4x
P/S RatioIs 688075 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688075 income statement (TTM) | |
|---|---|
| Revenue | CN¥511.29m |
| Cost of Revenue | CN¥315.59m |
| Gross Profit | CN¥195.70m |
| Other Expenses | CN¥34.79m |
| Earnings | CN¥160.91m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | 1.27 |
| Gross Margin | 38.28% |
| Net Profit Margin | 31.47% |
| Debt/Equity Ratio | 0.02% |
How did 688075 perform over the long term?
See historical performance and comparison